CA
NZ
UK
AU
IND
US
Gran Tierra Energy Inc. filed a Form 8-K on August 5, 2026, disclosing that it entered into a Share Sale and Purchase Agreement on that same date to sell its Colombia and Ecuador operations to Maurel & Prom Andina for total consideration of $1.33 …
Atlas Energy Solutions Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 5, 2026, covering the period ended June 30, 2026.
Gran Tierra Energy Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2026, with the SEC on August 5, 2026, disclosing revenue and expense figures for the three and six months ended June 30, 2026.
Bristow Group Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 5, 2026, reporting revenues, earnings, and balance sheet data for the three and six months ended June 30, 2026.
Icahn Enterprises L.P. filed its quarterly report on Form 10-Q with the SEC for the period ended June 30, 2026, disclosing condensed consolidated balance sheet figures and unit counts as of August 4, 2026.
LeMaitre Vascular, Inc. filed its quarterly report on Form 10-Q with the SEC on August 5, 2026, covering the three- and six-month periods ended June 30, 2026, for its common stock listed on The Nasdaq Global Market under the ticker LMAT.
Owens Corning filed its quarterly report on Form 10-Q for the period ended June 30, 2026 with the U.S. Securities and Exchange Commission, disclosing second-quarter and first-half financial results including net sales, earnings from continuing and discontinued operations, and balance sheet data.
United Therapeutics Corporation filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 5, 2026, reporting net income of $333.0 million for the second quarter and $607.9 million for the first half of …
Recursion Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission for the quarterly period ended June 30, 2026, submitted on August 5, 2026.
CVS Health Corporation filed its quarterly report on Form 10-Q with the SEC on August 5, 2026, covering the three and six months ended June 30, 2026, disclosing revenue, earnings, and balance sheet data for the period.
Please wait processing your request...